Skip to content

Clinical trials

Phase 1/2 Blastic Plasmacytoid Dendritic Cell Neoplasm trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm Phase: Phase 1/2 Country / region: China Clear all

2 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Biotech1
Chongqing Precision Biotech Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Blastic Plasmacytoid Dendritic Cell Neoplasm2
Leukemia, Myeloid, Acute2
Burkitt Lymphoma1
Hematologic Neoplasms1
Leukemia1
Leukemia, Plasma Cell1
Lymphoma, B-Cell1
Lymphoma, T-Cell, Peripheral1
Multiple Myeloma1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Showing 1 to 2 of 2. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.